XML 56 R20.htm IDEA: XBRL DOCUMENT v3.23.2
GENERAL - Identifiable net assets of Gesher (Details)
 6 Months Ended
Jan. 25, 2023
USD ($)
$ / shares
Jun. 30, 2023
USD ($)
Options
Dec. 31, 2022
Options
Jun. 30, 2022
Options
Dec. 31, 2021
Options
Dec. 31, 2020
Options
Disclosure of detailed information about biological assets [line items]            
Shares issued to Gesher shareholders | Options   1,195,671 1,228,410 1,600,499 1,600,499 0
IFRS 2 Listing expenses (A+B-C) $ 46,717,000 $ 46,717,000        
Gesher            
Disclosure of detailed information about biological assets [line items]            
Shares issued to Gesher shareholders 4,287,156          
Opening price of the Company's share on Nasdaq as of January 25, 2023 ($) | $ / shares $ 10.23          
(A) Fair value of the Company's shares issued to Gesher shareholders $ 43,858,000          
Opening price of the Company's warrants on Nasdaq as of January 25, 2023 ($) | $ / shares $ 0.74          
(B) Fair value of the Company's warrants issued to Gesher shareholders $ 9,012,000          
Gesher's cash in trust 8,127,000          
Gesher's liabilities (1,974,000)          
(C) Net assets of Gesher 6,153,000          
IFRS 2 Listing expenses (A+B-C) $ 46,717,000          
Gesher | Warrants            
Disclosure of detailed information about biological assets [line items]            
Shares issued to Gesher shareholders 12,250,000